Literature DB >> 11549707

A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans.

Y Hataya1, T Akamizu, K Takaya, N Kanamoto, H Ariyasu, M Saijo, K Moriyama, A Shimatsu, M Kojima, K Kangawa, K Nakao.   

Abstract

The synergistic relationship between GH-releasing secretagogue (GHS) and GH-releasing hormone (GHRH) with respect to GH secretion is well known. In the present study, we report a similar relationship between GHRH and ghrelin, a recently identified endogenous ligand for the GHS receptor. In normal male adults, various doses of ghrelin were intravenously administered alone or together with 1.0 microg/kg GHRH. At small doses of 0.08 and 0.2 microg/kg ghrelin, combined administration of the two peptides significantly stimulated GH release in a synergistic manner; the mean GH response values of the two peptide combinations were more than the summed mean GH response values of each peptide alone (P < 0.05). In addition, at 1.0 microg/kg ghrelin, the tendency of the synergistic effect was observed, although the comparison was not statistically significant probably due to a submaximal dose ceiling effect. No synergistic effects with respect to ACTH or prolactin secretion were observed. In conclusion, the synergistic interaction between ghrelin and GHRH was clearly shown and might be useful for a provocation test to diagnose GH deficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549707     DOI: 10.1210/jcem.86.9.8002

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  47 in total

1.  Effect of ghrelin and metoclopramide on prolactin secretion in normal women.

Authors:  C I Messini; K Dafopoulos; N Chalvatzas; P Georgoulias; G Anifandis; I E Messinis
Journal:  J Endocrinol Invest       Date:  2010-06-04       Impact factor: 4.256

2.  Deletion of ghrelin impairs neither growth nor appetite.

Authors:  Yuxiang Sun; Saira Ahmed; Roy G Smith
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.

Authors:  Catalina Norman; Nanette L Rollene; Dana Erickson; John M Miles; Cyril Y Bowers; Johannes D Veldhuis
Journal:  Eur J Endocrinol       Date:  2013-11-29       Impact factor: 6.664

4.  Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men.

Authors:  Johannes D Veldhuis; Dana Erickson; Jean Wigham; Sue Weist; John M Miles; Cyril Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

5.  Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system.

Authors:  L M Seoane; O Al-Massadi; F Barreiro; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

6.  Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease.

Authors:  Valentina Gasco; Alessandro Berton; Mirko Parasiliti Caprino; Ioannis Karamouzis; Mauro Maccario; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2014-12-09       Impact factor: 3.633

Review 7.  Clinical review: The human experience with ghrelin administration.

Authors:  Margaret C Garin; Carrie M Burns; Shailja Kaul; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

8.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

9.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

Review 10.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.